Lv6
2610 积分 2021-05-31 加入
Life's Essential 8 and 10-Year and Lifetime Risk of Atherosclerotic Cardiovascular Disease in China
11天前
已完结
Physical Activity and Excess Body Weight and Adiposity for Adults. American College of Sports Medicine Consensus Statement
28天前
已完结
Association between Life’s Essential 8 and risk of heart failure: findings from the Kailuan study
28天前
已完结
Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro
2个月前
已完结
中国中青年人心血管病余生风险评估:心血管病预防要从年轻开始
2个月前
已完结
心血管疾病终生风险的研究现状
2个月前
已完结
难治性与极端难治性高血压的药物治疗
3个月前
已完结
Dual Endothelin Antagonism with Aprocitentan as a Novel Therapeutic Approach for Resistant Hypertension
3个月前
已关闭
Pharmacological Characterization of Aprocitentan, a Dual Endothelin Receptor Antagonist, Alone and in Combination with Blockers of the Renin Angiotensin System, in Two Models of Experimental Hypertension
3个月前
已完结
皖公网安备34019202002308
